Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran

Erratum

After publication of the original article [1], the authors noticed that the percentages in Table 2 were incorrect.

Table 2 Comparison of the cumulative incidence rates of complications in the first, second and third doses of the vaccination in children

The correct version of Table 2 is published in this erratum.

Reference

  1. 1.

    Karami M, et al. Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC Immunol. 2017;18:42. doi:10.1186/s12865-017-0226-8.

Download references

Author information

Correspondence to Manoochehr Karami.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Karami, M., Ameri, P., Bathaei, J. et al. Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC Immunol 18, 45 (2017). https://doi.org/10.1186/s12865-017-0228-6

Download citation